Pre-Immunization and Immunotherapy in HIV(+) Patients
Country:
US
Docket No:
436313-001137
Publication Number:
11,090,379
Patent Expiry:
07/05/2037
Claims Scope:
Patent issued August 17, 2021.
Method and composition claims containing vectors that include (i) at least 2 of the microRNA backbone + guide sequences or (ii) each of the guide sequences.
–
A lentiviral vector comprising at least one encoded genetic element, wherein the at least one encoded genetic element comprises at least two of: (i) a sequence comprising at least 80% sequence identity with SEQ ID NO: 1, (ii) a sequence comprising at least 80% sequence identity with SEQ ID NO: 2, and (iii) a sequence comprising at least 80% sequence identity with SEQ ID DNO: 3; or each of: (iv) a sequence comprising at least 80% sequence identity with SEQ ID NO: 97, (v) a sequence comprising at least 80% sequence identity with SEQ ID NO: 6, and (vi) a sequence comprising at least 80% sequence identity with SEQ ID NO: 7.